Clinical trial
Sirolimus for Focal Segmental Glomerulosclerosis
NCT00040508 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00040508 |
|---|---|
| Title | Sirolimus for Focal Segmental Glomerulosclerosis |
| Official title | Sirolimus for Focal Segmental Glomerulosclerosis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Focal Glomerulosclerosis |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 30 |
| Start date | Jun 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Jun 27, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: